Given that these therapeutics have demonstrated efficacy in improving hyperlipidemia, promoting weight loss, and reducing glycated hemoglobin levels, the implementation of GLP-1 RA could lead to improved outcomes in the management of PCOS [7]. This evidence concerns the gene GLP1R and polycystic ovary syndrome.